Medicine Details
Brand name – Ledikast
Generic name – Sofosbuvir/Ledipasvir
Manufacturer – Natco
Marketed by – Aprazer
Salt composition – Sofosbuvir and Ledipasvir
Storage – Store at room temperature (10-30°C)
Dosage form – Oral (tablet)
Strength – 400mg + 90mg
Packaging – Bottle of 28 tablets
Gender – Unisex
Prescription required -Yes
Indication – Used in the treatment of chronic Hepatitis C Virus (HCV) infection
Description
Ledikast (400 mg + 90 mg) tablet is a combination of two antiviral medicines: Sofosbuvir and Ledipasvir. This medication is used in the treatment of chronic (long lasting) Hepatitis C Virus (HCV) infection in adults. Ledikast tablets help to improve the liver function by lowering the multiplication of virus in the body, and reduces the damage.
Pharmacodynamics
Sofosbuvir inhibits the RNA polymerase that the hepatitis C virus uses to replicate its RNA. Ledipasvir inhibits an important viral phosphoprotein, NS5A, which is involved in viral replication, assembly, and secretion.
Ingredients
The active ingredient of Ledikast tablet is Sofosbuvir/Ledipasvir (400mg/90mg).
Usage Of Medicine
Ledikast (Sofosbuvir/Ledipasvir) tablet is used in the treatment of chronic Hepatitis C Virus (HCV) infection in adults.


